CLASS II Drug recall · Reported 6 Dec 2017 · FDA Enforcement Report

Paroxetine Tablets USP, 30 mg, a) recalled by Zydus Pharmaceuticals USA

Zydus Pharmaceuticals USA is recalling Paroxetine Tablets USP, 30 mg, a) (, distributed nationwide in the US. The recall was initiated on 20 Nov 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesa) Z701308, b) Z701309, c) Z701310 exp April 2019
NDC68382-001, 68382-097, 68382-098, 68382-099
UPC0368382098108, 0368382099105
Quantity recalled19812 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0101-2018
FDA event ID
78612
Recalling firm
Zydus Pharmaceuticals USA, Pennington, NJ
Manufacturer
Zydus Pharmaceuticals USA Inc.
Classification
Class II
Status
Terminated
Recall initiated
20 Nov 2017
FDA classified
30 Nov 2017
Reported
6 Dec 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Antidepressants

Timeline

20 Nov 2017Recall initiated by company
30 Nov 2017Classified by FDA+10 days
6 Dec 2017Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets

Product as listed by the FDA

Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count (NDC 68382-099-05), and c) 1000 count (NDC 68382-099-10) count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is Paroxetine Tablets USP, 30 mg, a) ( recalled?

Yes. Zydus Pharmaceuticals USA recalled Paroxetine Tablets USP, 30 mg, a) ( on 20 Nov 2017. The recall is Class II and its status is Terminated. Recall number D-0101-2018.

Why was it recalled?

Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets

Which lots are affected?

a) Z701308, b) Z701309, c) Z701310 exp April 2019

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zydus Pharmaceuticals USA

All 95

Other Paroxetine recalls

All 16